OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with ...
Pneumococcal conjugate vaccines (PCVs) reduce disease and colonization by the serotypes they cover. As of now, the Advisory Committee on Immunization Practices (ACIP) recommends that PCV15 and PCV20 ...
Seeking Alpha: CVS Health announces availability of flu vaccines in CVS Pharmacy
CVS Health (NYSE:CVS) has announced the availability of updated flu vaccines for the 2025-2026 season at CVS Pharmacy and MinuteClinic locations across the country. In addition to the vaccines, ...
The following summarizes CDC's current age- and risk-based pneumococcal vaccine recommendations. Access the official, full text of CDC's current and historical pneumococcal vaccine recommendations.
Yahoo: 50 or Older? The Pneumococcal Pneumonia Vaccine is Recommended for You
NBC Chicago: People 50 and older should get pneumococcal vaccine, CDC recommends
WOONSOCKET, R.I., Sept. 3, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that updated 2025-2026 flu vaccines are available at CVS Pharmacy® and MinuteClinic® locations nationwide.
MedPage Today: Next-Generation Pneumococcal Conjugate Vaccines May Prevent Much Adult Pneumococcal Disease
—Among adults, coverage and preventable burdens were lowest for pneumococcal conjugate vaccine (PCV) 15 and highest for PCV31, with PCV21 preventing notable burdens of both acute respiratory ...
Medscape: Pneumococcal Conjugate Vaccine V116 Extends Protection to Adults Living With HIV
In adults living with HIV, the 21-valent pneumococcal conjugate vaccine (PCV) V116 was well tolerated and effective against all 21 target serotypes. The immune responses were comparable to those ...
MedPage Today: Newer Pneumococcal Conjugate Vaccines Hold Promise for Preventing Pediatric Disease
The following summarizes CDC's current age- and risk-based pneumococcal vaccine recommendations. Access the official, full text of CDC's current and historical pneumococcal vaccine …
This page tells you all you need to know about the symptoms, treatment and prevention of pneumococcal pneumonia. Access the Mayo Clinic Vaccine Planner to help you identify vaccines that …
MedPage Today: Pneumococcal Conjugate Vaccine 20 May Prevent Up to 25% More Pediatric Invasive Pneumococcal Disease Cases
Pneumococcal Conjugate Vaccine 20 May Prevent Up to 25% More Pediatric Invasive Pneumococcal Disease Cases
Vaccines can help protect older adults from certain illnesses. Healthcare professionals recommend specific vaccines for older adults, such as flu, pneumococcal, and Tdap. Vaccines can be essential for ...
Merck's pneumococcal vaccine showed strong immune responses in children and teens who are at higher risk of serious illness in a late-stage study, the drugmaker said on Thursday. The shot, Capvaxive, ...
Seeking Alpha: Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV ...
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV ...
Sept 11 (Reuters) - Merck's (MRK.N), opens new tab pneumococcal vaccine triggered immune responses in children and teens who are at higher risk of serious illness in a late-stage study, the drugmaker ...
This page tells you all you need to know about the symptoms, treatment and prevention of pneumococcal pneumonia. Access the Mayo Clinic Vaccine Planner to help you identify vaccines that match your personal needs.
Retailers such as CVS Health, Meijer, Target, Schnucks, Kroger and Giant Food are offering updated flu vaccines. Meijer Pharmacy is reaffirming its commitment to protecting Midwest communities with a ...
ROCKFORD, Ill. (WIFR) - Updated 2025-2026 flu vaccines are available CVS Pharmacy and MinuteClinic locations worldwide. According to the Centers for Disease Control and Prevention, annual flu shots ...
Merck & Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical ...
Nasdaq: Merck Announces VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) Met Key Immunogenicity and Safety Endpoints in Phase 3 Pivotal Trial Evaluating Use in Infants, PNEU ...
Merck Announces VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) Met Key Immunogenicity and Safety Endpoints in Phase 3 Pivotal Trial Evaluating Use in Infants, PNEU ...
FierceBiotech: Merck's next-gen pneumococcal vaccine strides forward after 2 phase 3 wins
Merck & Co.’s next-generation pneumococcal vaccine has secured success in a pair of phase 3 trials, bringing the Big Pharma within touching distance of getting the first pneumococcal conjugate shot ...
Vaxcyte's (NASDAQ:PCVX) investigational 24-valent pneumococcal conjugate vaccine (PCV), VAX-24, has shown a safety and tolerability profile comparable to Pfizer's (PFE) Prevnar 20 shot for the ...
Nasdaq: Merck Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults
Merck Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults
Pneumococcal vaccines are the most effective way to protect yourself or your child against pneumococcal disease, and may help prevent infections including ear infections, pneumonia (lung infection), ...
Approved 15 months ago as a pneumococcal disease vaccine for adults—and billed as the first shot designed for seniors—Merck’s Capvaxive now has data supporting its potential in children and ...
An additional dose of a pneumococcal vaccine, either 23-valent pneumococcal polysaccharide vaccine (PPV23) or 20-valent pneumococcal conjugate vaccine (PCV20), for new care home residents upon entry ...
Last week Merck announced topline results from a phase 3 pivotal trial in which a four-dose regimen of the 15-valent pneumococcal conjugate vaccine Vaxneuvance (PCV15) met key immunogenicity and ...
Credit: Getty Images. V116 is an investigational 21-valent pneumococcal conjugate vaccine. Merck’s investigational 21-valent pneumococcal conjugate vaccine, V116, elicited positive immune responses in ...
Odessa American: 50 or older? The pneumococcal pneumonia vaccine is recommended for you
Healio: What physicians need to know to ensure simpler pneumococcal vaccine management
Business Wire: CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
Pneumococcal disease is an infection you get from S. pneumonia. It may be mild or cause severe illness, including pneumonia. Treatment includes antibiotics.
The risk of pneumococcal infection is much increased in persons with impaired IgG synthesis, impaired phagocytosis, or defective clearance of pneumococci.